Acute effect of β-sitosterol on calcium uptake mediates anti-inflammatory effect in murine activated neutrophils

J Pharm Pharmacol. 2013 Jan;65(1):115-22. doi: 10.1111/j.2042-7158.2012.01568.x. Epub 2012 Oct 11.

Abstract

Objectives: To evaluate the effect of β-sitosterol on ⁴⁵Ca²⁺ uptake in activated murine neutrophils, and upon myeloperoxidase and adenosine deaminase activity, and interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) levels, in carrageenan-induced inflammation in the mouse air pouch model.

Methods: Dried Esenbeckia leiocarpa bark was macerated and extracted resulting in a crude hydroalcoholic extract (CHE) that was partitioned to obtain an alkaloid fraction. The alkaloid was then partitioned in polar and nonpolar subfractions. β-Sitosterol was isolated from the nonpolar subfraction and identified by comparison with the literature. The effect of β-sitosterol on ⁴⁵Ca²⁺ uptake in activated murine neutrophils, and upon myeloperoxidase and adenosine deaminase activity, IL-1β and TNF-α levels in carrageenan-induced inflammation in mice were evaluated.

Key findings: β-Sitosterol promoted a time- and dose-dependent increase of the calcium uptake in activated neutrophils that was promptly reversed by nifedipine, BAPTA-AM, LY294002, and colchicine. β-Sitosterol inhibited myeloperoxidase and adenosine deaminase activity, and IL-1β and TNF-α levels.

Conclusions: β-Sitosterol inhibited either myeloperoxidase and adenosine deaminase activity or IL-1β and TNF-α levels. This effect seemed to be mediated by the calcium uptake in activated neutrophils in a time- and concentration-dependent manner through L-type voltage dependent calcium channels, intracellular calcium, phosphoinositide kinase-3, and microtubule modulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / blood
  • Adenosine Deaminase / chemistry
  • Adenosine Deaminase / metabolism
  • Adenosine Deaminase Inhibitors / administration & dosage
  • Adenosine Deaminase Inhibitors / pharmacology
  • Adenosine Deaminase Inhibitors / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / chemistry
  • Calcium Channels, L-Type / metabolism*
  • Calcium Signaling / drug effects*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Hypolipidemic Agents / administration & dosage
  • Hypolipidemic Agents / pharmacology*
  • Hypolipidemic Agents / therapeutic use
  • Injections, Intraperitoneal
  • Interleukin-1beta / antagonists & inhibitors
  • Interleukin-1beta / blood
  • Interleukin-1beta / metabolism
  • Mice
  • Microtubules / drug effects
  • Microtubules / metabolism
  • Neutrophil Activation / drug effects
  • Neutrophils / drug effects*
  • Neutrophils / immunology
  • Neutrophils / metabolism
  • Peroxidase / antagonists & inhibitors
  • Peroxidase / blood
  • Peroxidase / metabolism
  • Phosphatidylinositol 3-Kinase / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Pleurisy / immunology*
  • Pleurisy / metabolism
  • Pleurisy / prevention & control
  • Sitosterols / administration & dosage
  • Sitosterols / pharmacology*
  • Sitosterols / therapeutic use
  • Tubulin Modulators / pharmacology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Adenosine Deaminase Inhibitors
  • Anti-Inflammatory Agents
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Enzyme Inhibitors
  • Hypolipidemic Agents
  • Interleukin-1beta
  • Phosphoinositide-3 Kinase Inhibitors
  • Sitosterols
  • Tubulin Modulators
  • Tumor Necrosis Factor-alpha
  • gamma-sitosterol
  • Peroxidase
  • Phosphatidylinositol 3-Kinase
  • Adenosine Deaminase